Advanced Biomed Inc. Common Stock (ADVB) — Cash Flow-to-Debt Ratio
Advanced Biomed Inc. Common Stock (ADVB) has a Cash Flow-to-Debt Ratio of 0.00x as of March 2026, meaning its operating cash flow of $-6.89K could theoretically repay 0% of its total liabilities ($1.44 Million) in one year. See ADVB free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Advanced Biomed Inc. Common Stock Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for Advanced Biomed Inc. Common Stock across 5 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Advanced Biomed Inc. Common Stock.
Annual Cash Flow-to-Debt Ratio for Advanced Biomed Inc. Common Stock (2021–2025)
Year-by-year debt coverage analysis for Advanced Biomed Inc. Common Stock. Check Advanced Biomed Inc. Common Stock (ADVB) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.06x | $-181.46K | $3.03 Million | ▲ +92.1% |
| 2024 | -0.76x | $-2.13 Million | $2.80 Million | ▲ +15.5% |
| 2023 | -0.90x | $-2.96 Million | $3.29 Million | ▼ -290.9% |
| 2022 | -0.23x | $-741.45K | $3.22 Million | ▲ +98.5% |
| 2021 | -15.73x | $-473.98K | $30.13K | — |